targeted therapy

Side-Out Protocol: Year One

Fairfax, VA — March 29, 2011 — The Side-Out Foundation is funding a study looking at a novel approach in treating patients living with advanced breast cancer. This clinical trial (SO-BCA-001) is laying the groundwork for biologically based treatments for breast cancer, utilizing molecular profiling of the patient’s tumor tissue to find potential targets and

Side-Out Protocol: Year One Read More »

An Interview With Daniel Von Hof, M.D. “Context of Vulnerabilty”

Daniel Von Hoff, MD is the Chief Scientific Officer for US Oncology Research. A truly inspiring leader, he is a graduate of Columbia College of Physicians and Surgeons. He has served as a Professor in multiple departments at the University of Texas Health Science Center in San Antonio, the University of Texas at Austin, and

An Interview With Daniel Von Hof, M.D. “Context of Vulnerabilty” Read More »